Dr. Reddy's Laboratories
134 hedge funds and large institutions have $1B invested in Dr. Reddy's Laboratories in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 51 increasing their positions, 49 reducing their positions, and 36 closing their positions.
4% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 49
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less ownership
Funds ownership: 82.46% → 75.46% (-7%)
18% less funds holding
Funds holding: 164 → 134 (-30)
19% less capital invested
Capital invested by funds: $1.24B → $1B (-$234M)
67% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 36
68% less call options, than puts
Call options by funds: $458K | Put options by funds: $1.42M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$57.5M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$5.61M |
| 3 |
DI
Dalton Investments
Las Vegas,
Nevada
|
+$5.36M |
| 4 |
Renaissance Technologies
New York
|
+$4.76M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Vontobel Asset Management
New York
|
-$55.2M |
| 2 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$24.1M |
| 3 |
JP Morgan Chase
New York
|
-$14.6M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$12.3M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$9.23M |
RDY Hedge Fund Activity: Q1 2017 in Review
134 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2017, worth a combined $1B — down 19% from $1.24B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of RDY and 12 opened new positions — a net loss of 24 holders — while 49 trimmed existing stakes and 51 added.
The largest buyer was BlackRock, adding an estimated $57.5M. The largest seller was Vontobel Asset Management, exiting entirely with an estimated $55.2M sold.
- 134 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2017, down from 164 in Q4 2016.
- Funds reported $1B of Dr. Reddy's Laboratories stock for Q1 2017, down 19% quarter-over-quarter.
- 12 funds opened new Dr. Reddy's Laboratories positions in Q1 2017 and 36 closed out, a net change of -24 holders.
- The largest Dr. Reddy's Laboratories buyer in Q1 2017 was BlackRock, an estimated $57.5M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2017 was Vontobel Asset Management, an estimated $55.2M sold.
Based on aggregated 13F filings for Q1 2017.